People with HER2+/HR+ advanced breast cancer had the longest survival times — 42 months on average at the start and 53 months ...
A new study published in Frontiers of Engineering Management presents a comprehensive evaluation system to assess innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback